0.5939

6.07% 0.034

After Hours: .60 0.0061 +1.03%

Tc Biopharm Holdings Plc Adr (TCBP)

Overview News Price History Discussions Forecast Stock Split

Tc Biopharm Holdings Plc Adr stock is traded at $0.5939, with a volume of 263.41K. It is up +6.07% in the last 24 hours and down -54.66% over the past month. TC BioPharm (Holdings) PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapy products that are based on its proprietary allogeneic gamma delta T (abbreviated as GD-T) cell platform. Harnessing the innate ability of GD-Ts has enabled the company to develop a range of clinical-stage cell therapies designed to combat cancer and viral infection.

Previous Close:

$0.5599

Open:

$0.543

24h Volume:

263.41K

Relative Volume:

0.22

Market Cap:

$319.82K

Revenue:

$4.60M

Net Income/Loss:

$-7.33M

P/E Ratio:

0.0128

EPS:

46.49

Net Cash Flow:

$-13.42M

1W Performance:

-9.47%

1M Performance:

-54.66%

6M Performance:

-94.50%

1Y Performance:

-99.25%

1-Day Range:

$0.483

$0.61

1-Week Range:

$0.4359

$0.6615

52-Week Range:

$0.4359

$78.00

Tc Biopharm Holdings Plc Adr Stock (TCBP) Company Profile

Name

Tc Biopharm Holdings Plc Adr

Sector

Healthcare (1203)

Industry

Biotechnology (683)

Phone

01414337557

Address

MAXIM 1, HOLYTOWN

Employee

Twitter

Next Earnings Date

Latest SEC Filings

TCBP's Discussions on Twitter

Compare TCBP with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
TCBP Tc Biopharm Holdings Plc Adr	0.5939	319.82K	4.60M	-7.33M	-13.42M	-5.0566
VRTX Vertex Pharmaceuticals Inc	465.73	119.71B	10.63B	-479.80M	-1.35B	-1.99
REGN Regeneron Pharmaceuticals Inc	762.34	82.77B	13.85B	4.65B	3.32B	40.41
ARGX Argen X Se Adr	617.49	36.87B	1.86B	-40.29M	-1.28B	-0.85
ALNY Alnylam Pharmaceuticals Inc	253.01	32.63B	2.09B	-332.26M	16.06M	-2.62
BNTX Biontech Se Adr	117.20	28.10B	3.30B	-501.07M	1.03B	-2.1146

Tc Biopharm Holdings Plc Adr Stock (TCBP) Latest News

Nov 25, 2024

TC Biopharm Faces Financial Strains Amid Rising Costs - TipRanks

Nov 25, 2024

Nov 12, 2024

TC Biopharm awarded funding of $250,000 from G-Rex Grant Program - TipRanks

Nov 12, 2024

Oct 30, 2024

TC BioPharm advances cancer therapy trials, raises $8M By Investing.com - Investing.com South Africa

Oct 30, 2024

TC BioPharm advances cancer therapy trials, raises $8M - Investing.com India

Oct 30, 2024

Oct 25, 2024

TC Biopharm refutes social media claim, remains compliant with Nasdaq rules - TipRanks

Oct 25, 2024

TC BioPharm denies Nasdaq delisting rumors - Investing.com

Oct 25, 2024

Oct 22, 2024

TC Biopharm enters research pact with Dr. Carlos Maluquer de Motes - TipRanks

Oct 22, 2024

Oct 21, 2024

TC Biopharm (Holdings) PLC – ADR trading halted, volatility trading pause - TipRanks

Oct 21, 2024

Oct 08, 2024

TCBP Stock Update: TC BioPharm (Holdings) plc ADR’s Banking’s Market Struggles and Potential Opportunities - The InvestChronicle

Oct 08, 2024

Oct 05, 2024

TC Biopharm announces artificial intelligene initiative with Carnegie Mellon - TipRanks

Oct 05, 2024

Sep 12, 2024

TC Biopharm announces first patient completes full dose regimen in ACHIEVE trial - TipRanks

Sep 12, 2024

Sep 09, 2024

TC BioPharm to start preclinical studies on monkeypox therapy - Investing.com India

Sep 09, 2024

TC Biopharm intends to launch preclinical study for treatment of Mpox - TipRanks

Sep 09, 2024

Sep 06, 2024

TC BioPharm to begin monkeypox treatment studies - Investing.com

Sep 06, 2024

Sep 04, 2024

TCBP’s Market Moves: -77.03% YTD Growth, -42.22% 6-Month loss, 68.52% in 30 Days - The InvestChronicle

Sep 04, 2024